The latest health news
The chief executive of biotech Athira Pharma has permanently left the company after papers she published as a graduate student were found to contain altered research. Leen Kawas was suspended …
Read More
Is Moderna misunderstood? Can Biogen turn a profit in Alzheimer’s disease? And what went wrong with the latest Covid-19 pill? We cover all that and more this week on “The …
Read More
Tranche is a French word meaning slice, and that’s pretty much what it means in the language of venture capital as well. When a company raises a huge sum of …
Read More
Did we learn anything from the Martin Shkreli saga? Who will run the NIH? And what does science owe Henrietta Lacks? We cover all that and more this week on …
Read More
An $11 billion biopharma acquisition. Health equity “tourism.” And, where can you buy a 12-foot pyramid of bones? We cover all that and more this week on “The Readout LOUD,” …
Read More
Harvard scientist George Church, a pioneer of both DNA sequencing and gene editing, has been talking in the press for more than a decade about the possibility of bringing the …
Read More
Are we ever getting that Tricorder? Why’s it so hard to find Covid-19 tests? And is misinformation stopping Biogen from making money? We cover all that and more this week …
Read More
Biogen CEO Michel Vounatsos admitted Thursday that the launch of Aduhelm, the company’s intensely scrutinized treatment for Alzheimer’s disease, has been “slower than we anticipated,” which he blamed in part …
Read More
French drug maker Sanofi said Wednesday that it will acquire Kadmon Pharmaceuticals for $1.9 billion, bolstering its transplant medicines business with a newly approved treatment for graft-versus-host disease. The all-cash …
Read More